Every I.V. site presents the potential for infection, dislodgement, skin damage, and other complications. These complications can potentially cause patient discomfort and pain, extended hospital stays, additional therapy, and surgical intervention—even increased patient mortality.
3M Science has allowed for innovations that give you what you need to protect every I.V. catheter—from insertion to removal.
Our broad portfolio makes it easy for you to choose and use the right products: from hand hygiene, skin preps and barrier films, and transparent dressings.
We can help you deliver compassionate care with evidence-based products to protect patient and clinician safety, help prevent the risks of costly complications, and improve patient satisfaction.
Catheter-related bloodstream infections (CRBSIs) are one of the most serious and costly health care-acquired infections (HAIs), leading to increased costs associated with extended hospital stays, illness and death. The estimated average cost for treating a single CRBSI is $29,5001 per episode in Australia and between $20,000 to $54,000 2 in New Zealand.
Choose 3M Tegaderm Chlorhexidine Gluconate (CHG) Securement dressing with an integrated antimicrobial Chlorhexidine Gluconate (CHG) gel pad to help reduce the risk of contamination from flora on the surface of the skin.3
3M™ Tegaderm™ I.V. Advanced Securement Dressings include a deep notch, stabilisation border, and dual adhesive technology to provide the comfort and protection your patients deserve. These dressings meet the CDC and INS definitions as a catheter securement or stabilisation device.4,5
Providing exceptional I.V. site care is a tough job. You’re expected to ensure I.V. sites are stable and secure, manage the risks of healthcare-acquired infections, provide a positive patient experience whilst keeping an eye on the bottom line.
The Centers for Disease Control and Prevention (CDC) Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011 and The Infusion Nurses Society (INS) Nursing Standards of Practice, 2011, recommend the use of a catheter stabilisation device for all I.V. catheters.4,5
The thin film backing of 3M™ Tegaderm™ Transparent Film Dressings provides a barrier to liquids, bacteria and viruses,* yet allows water vapor, oxygen and carbon dioxide to be exchanged. The sterile film includes a latex-free hypoallergenic, flexible adhesive which enables long wear time and full site visibility to minimise unnecessary dressing changes.
* In vitro testing shows that the transparent film provides a viral barrier from viruses 27 nm in diameter or larger while the dressing remains intact without leakage.
Maintenance of healthy skin around a vascular access device is critical to reducing the risk of infection, maintaining a securement dressing or device, and patient comfort. Although Medical Adhesive-Related Skin Injuries (MARSI) continue across care specialties, they do not need to be an inevitable part of the patient experience. Skin integrity can be maintained even when repeated dressing changes are required. Preparation of the skin and selection of proper adhesives are the first steps to help minimise the risks of MARSI.6
3M™ Cavilon™ No Sting Barrier Film forms a protective barrier between the skin and the adhesive of the securement dressing, device or medical tape to help reduce the risk of Medical Adhesive-Related Skin Injury (MARSI). When an adhesive product is removed from the skin, Cavilon No Sting Barrier Film is removed instead of skin cells.6
3M™ Medical Tapes provide a variety of backings and adhesives that allow you to select the most appropriate adhesive product based on its intended purpose. To help reduce the risk of cross contamination among patients, 3M offers many of its tapes in single-patient use rolls.7
The Infusion Nurses Society (INS) has recently updated its Standards of Practices to reflect current infusion and vascular access practices. Lisa Gorski, chairman of both the 2011 and 2016 INS Standards of Practice Committee, presents a two-part program that updates Vascular Access clinicians and those responsible for the care and maintenance of Vascular Access Devices. The 2016 Infusion Therapy Standards of Practice reflect updated practice criteria that have been evaluated based on strength of evidence.
1. Collignon PJ et al (2007) Intravascular catheter bloodstream infections: an effective and sustained hospital-wide prevention program over 8 years. MJA Vol 187, No 10;p.551-554
2. Seddon ME, et al (2011). Aiming for zero: decreasing central line associated bacteremia in the intensive care unit. New Zealand Medical Journal (NZMA), July 2011; Vol 124No 1339
3. Mermel, LA, McCormick, RD, Springman, SR, Maki, DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: A prospective study utilizing molecular sub-typing. American Journal of Medicine. (1991) 91; 197S-205S.
4. Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-related Infections. Healthcare Infection Control (Appendix 1). Clin Infect Dis, 2011; 52(9):e162.
5. Infusion Therapy Standards of Practice, 2016.
6. McNichol L, Lund C, Rosen T, Gray M. Medical Adhesives and Patient Safety: State of the Science. Journal Wound Ostomy Continence Nursing. 2013; 40(4): 365-380.
7. Infection Control Today Vol 17, No. 1, Single-Patient Rolls of Medical Tapes Reduce Cross-Contamination Risk (January 2013).